Clarus Corp (NASDAQ:CLAR) reported second-quarter FY22 sales growth of 57% year-on-year to $114.93 million, beating the consensus of $110.16 million. Domestic…
Outlook: The Company is reintroducing both GAAP and non-GAAP pro forma adjusted guidance for 2022 (suspended on June 1, 2022) to reflect the results of the second quarter, as well as our
Outlook
Third Quarter 2022
The company expects third quarter 2022 adjusted net sales to increase 2% to 4% compared to the third quarter of 2021. This expectation includes an approximately 2 point additive impact from
Affirms full-year 2022 GAAP diluted EPS guidance range of $4.75 to $4.91, reflecting growth of 7% to 10% over full-year 2021 GAAP diluted EPS and growth
Guidance
The Company updates its full-year 2022 guidance that was initially provided on its year-end 2021 earnings release on February 17, 2022, based on year-to-date performance and to include the completed
In light of the continuing global supply chain and labor disruptions and net inflationary impacts, we are revising our FY22 guidance as follows:
Total net sales for 2022 are now expected to be
Counterpoint Global is Morgan Stanley’s (NYSE: MS) Investment Management division in charge of understanding new or “disruptive” market opportunities that hold “the potential to trigger far-reaching consequences” and therefore constitute a likely sound, long-term i